Παραπομπή σε μορφή APA (7η εκδ.)

(13263834), K. H., (5506013), F. X., (586649), L. X., & (2826512), Y. L. (2025). Albumin–globulin ratio is a predictive biomarker of antitumour effect of immune checkpoint inhibitors in cancer patients.

Παραπομπή σε μορφή Chicago (17η εκδ.)

(13263834), Kaixiang He, Fujiang Xu (5506013), Li Xiang (586649), και Yuhao Luo (2826512). Albumin–globulin Ratio Is a Predictive Biomarker of Antitumour Effect of Immune Checkpoint Inhibitors in Cancer Patients. 2025.

Παραπομπή σε μορφή MLA (9th εκδ.)

(13263834), Kaixiang He, et al. Albumin–globulin Ratio Is a Predictive Biomarker of Antitumour Effect of Immune Checkpoint Inhibitors in Cancer Patients. 2025.